{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:36:05Z","timestamp":1791221765238,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01ES012933"],"award-info":[{"award-number":["R01ES012933"]}]},{"name":"NIH","award":["DK071073"],"award-info":[{"award-number":["DK071073"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bcp.2011.11.011","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T16:52:29Z","timestamp":1321980749000},"page":"995-1004","source":"Crossref","is-referenced-by-count":104,"title":["Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs"],"prefix":"10.1016","volume":"83","author":[{"given":"Xiangyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Ruden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.11.011_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-0381-4-15","article-title":"Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation","volume":"4","author":"Echeverria","year":"2011","journal-title":"BioData Min"},{"key":"10.1016\/j.bcp.2011.11.011_bib0010","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/emboj.2011.340","article-title":"FOXA1: master of steroid receptor function in cancer","volume":"30","author":"Augello","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2011.11.011_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-61779-295-3_3","article-title":"Hsp90 and client protein maturation","volume":"787","author":"Wayne","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0020","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.1105243108","article-title":"Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal","volume":"108","author":"Memarzadeh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.11.011_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.yhbeh.2010.05.018","article-title":"Epigenetic setting for long-term expression of estrogen receptor alpha and androgen receptor in cells","volume":"59","author":"Imamura","year":"2011","journal-title":"Horm Behav"},{"key":"10.1016\/j.bcp.2011.11.011_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-010-1526-x","article-title":"Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug","volume":"26","author":"Biggar","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0035","first-page":"441","article-title":"Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90","volume":"27","author":"Lee","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2011.03.004","article-title":"RNAi knockdown of Hop (Hsp70\/Hsp90 organising protein) decreases invasion via MMP-2 down regulation","volume":"306","author":"Walsh","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2011.11.011_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma","volume":"13","author":"Ou","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2011.11.011_bib0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11864-011-0147-3","article-title":"Other markers and potential treatment strategies for KRAS mutant and wild-type patients","volume":"12","author":"Cercek","year":"2011","journal-title":"Curr Treat Opt Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10495-010-0542-4","article-title":"Blocking NF-kappaB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death","volume":"16","author":"Bai","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2011.11.011_bib0060","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-11-0174","article-title":"Targeting heat shock protein 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myeloma","volume":"10","author":"Khong","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0065","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.2174\/092986711796011256","article-title":"Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies","volume":"18","author":"Beck","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10637-010-9441-3","article-title":"Ascorbate\/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study","volume":"29","author":"Beck","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2011.11.011_bib0075","first-page":"53","article-title":"Structural analysis of the interaction between Hsp90 and the tumor suppressor protein","author":"Hagn","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0080","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1158\/1078-0432.CCR-11-0592","article-title":"Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90","volume":"17","author":"Mehta","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0085","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-10-1689","article-title":"Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors","volume":"17","author":"Breinig","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0090","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-10-1927","article-title":"A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors","volume":"17","author":"Pacey","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2121-11-51","article-title":"Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits","volume":"11","author":"Stellas","year":"2010","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0100","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/cdd.2011.71","article-title":"SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis","volume":"18","author":"Li","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2011.11.011_bib0105","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2011.05.014","article-title":"Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor","volume":"35","author":"Yu","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0110","doi-asserted-by":"crossref","first-page":"e14573","DOI":"10.1371\/journal.pone.0014573","article-title":"Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2011.11.011_bib0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11010-010-0651-y","article-title":"Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90","volume":"348","author":"Meng","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0120","doi-asserted-by":"crossref","first-page":"875824","DOI":"10.1155\/2011\/875824","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/iub.288","article-title":"Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells","volume":"62","author":"Luo","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2011.11.011_bib0130","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1093\/hmg\/ddi103","article-title":"Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstilbesterol (DES) on uterine development and cancer","volume":"14","author":"Ruden","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bcp.2011.11.011_bib0135","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2011.11.011_bib0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1756-9966-30-58","article-title":"Oncogene addiction in gliomas: implications for molecular targeted therapy","volume":"30","author":"Yan","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1101\/sqb.2005.70.042","article-title":"Is oncogene addiction angiogenesis-dependent","volume":"70","author":"Folkman","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0150","first-page":"535","article-title":"Oncogene addiction: sometimes a temporary slavery","volume":"6","author":"Jonkers","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2011.11.011_bib0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1586\/14737140.2.6.611","article-title":"Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction","volume":"2","author":"Workman","year":"2002","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/path.2795","article-title":"GRP78 up-regulation is associated with androgen receptor status Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer","volume":"223","author":"Tan","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bcp.2008.10.019","article-title":"Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death","volume":"77","author":"Beck","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/cbt.7.1.5458","article-title":"HIF-1alpha and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations","volume":"7","author":"Kim","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0175","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1073\/pnas.0711993105","article-title":"IP6K2 is a client for HSP90 and a target for cancer therapeutics development","volume":"105","author":"Shames","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.11.011_bib0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jmb.2009.04.080","article-title":"pH-dependent conformational changes in bacterial Hsp90 reveal a Grp94-like conformation at pH 6 that is highly active in suppression of citrate synthase aggregation","volume":"390","author":"Krukenberg","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12079-011-0121-7","article-title":"Proteasome inhibitors in cancer therapy","volume":"5","author":"Crawford","year":"2011","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.bcp.2011.11.011_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2011.10.054","article-title":"Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors","volume":"415","author":"Singh","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2011.11.011_bib0195","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-11-0497","article-title":"Dual inhibition of tumor energy pathway by 2-deoxy glucose and metformin is effective against a broad spectrum of preclinical cancer models","author":"Cheong","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0200","first-page":"84","article-title":"An autophagy inhibitor enhances the inhibition of cell proliferation","volume":"5","author":"Yao","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bcp.2011.11.011_bib0205","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-03-1158","article-title":"Antimyeloma activity of heat shock protein-90 inhibition","volume":"107","author":"Mitsiades","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.11.011_bib0210","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1158\/1078-0432.CCR-11-0072","article-title":"HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab","volume":"17","author":"Modi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0215","article-title":"A phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma","author":"Pacey","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2011.11.011_bib0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00432-005-0047-7","article-title":"Hsp90 inhibitors cause G2\/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines","volume":"132","author":"Senju","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00280-007-0522-8","article-title":"Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo","volume":"61","author":"Schwock","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0230","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.juro.2007.05.120","article-title":"Intratumor injection of the Hsp90 inhibitor 17AAG decreases tumor growth and induces apoptosis in a prostate cancer xenograft model","volume":"178","author":"Williams","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0235","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1158\/1078-0432.CCR-08-1002","article-title":"Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma","volume":"14","author":"Solit","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0240","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1002\/chem.201001119","article-title":"Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studies","volume":"16","author":"Day","year":"2010","journal-title":"Chemistry"},{"key":"10.1016\/j.bcp.2011.11.011_bib0245","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2174\/092986708786242895","article-title":"Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket","volume":"15","author":"Donnelly","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0250","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/ci1001857","article-title":"Exploring the binding site of C-terminal hsp90 inhibitors","volume":"50","author":"Sgobba","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bcp.2011.11.011_bib0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3816\/CLC.2010.n.012","article-title":"New molecular targeted therapies integrated with radiation therapy in lung cancer","volume":"11","author":"Provencio","year":"2010","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.bcp.2011.11.011_bib0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.11.14","article-title":"Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives","volume":"7","author":"Lassi","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0265","doi-asserted-by":"crossref","first-page":"73ps8","DOI":"10.1126\/scitranslmed.3002137","article-title":"Dodging drug-resistant cancer with diamonds","volume":"3","author":"Merkel","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2010.136","article-title":"Drug resistance in metastatic castration-resistant prostate cancer","volume":"8","author":"Seruga","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0275","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","article-title":"Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress","volume":"25","author":"Zaugg","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2011.11.011_bib0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2180-11-104","article-title":"Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes","volume":"11","author":"Kawai","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1586\/era.10.224","article-title":"Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors","volume":"11","author":"Smith","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00109-010-0707-1","article-title":"Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation","volume":"89","author":"Chen","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.bcp.2011.11.011_bib0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/BJ20111333","article-title":"Treatment of doxorubicin resistant MCF7\/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance","volume":"440","author":"De Luca","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2011.11.011_bib0300","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2010.09.008","article-title":"UDP-glucuronosyltransferase 1A6 overexpression in breast cancer cells resistant to methotrexate","volume":"81","author":"de Almagro","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0305","article-title":"The \u2018active life\u2019 of Hsp90 complexes","author":"Prodromou","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.11.011_bib0310","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00109-004-0549-9","article-title":"Targeting multiple signal transduction pathways through inhibition of Hsp90","volume":"82","author":"Zhang","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0315","first-page":"2095","article-title":"Associations of HSP90 client proteins in human breast cancer","volume":"31","author":"Shipp","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/path.2795","article-title":"GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer","volume":"223","author":"Tan","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0325","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/EC.00009-07","article-title":"In the yeast heat shock response, Hsf1-directed induction of Hsp90 facilitates the activation of the Slt2 (Mpk1) mitogen-activated protein kinase required for cell integrity","volume":"6","author":"Truman","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bcp.2011.11.011_bib0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0906-6705.2004.00114.x","article-title":"Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases","volume":"13","author":"Becker","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0335","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.4049\/jimmunol.157.9.4109","article-title":"Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology","volume":"157","author":"Galea-Lauri","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(93)90306-8","article-title":"Induction of HSP90 alpha heat shock mRNA after transient global ischemia in gerbil hippocampus","volume":"621","author":"Kawagoe","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0345","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1126\/science.1195487","article-title":"Hsp90 and environmental stress transform the adaptive value of natural genetic variation","volume":"330","author":"Jarosz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.11.011_bib0350","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.11.011_bib0355","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nature749","article-title":"Hsp90 as a capacitor of phenotypic variation","volume":"417","author":"Queitsch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.011_bib0360","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/24550","article-title":"Hsp90 as a capacitor for morphological evolution","volume":"396","author":"Rutherford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.011_bib0365","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1067","article-title":"Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution","volume":"33","author":"Sollars","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2011.11.011_bib0370","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/MCB.10.4.1432","article-title":"Identification of Schizosaccharomyces pombe transcription factor PGA4, which binds cooperatively to Saccharomyces cerevisiae GAL4-binding sites","volume":"10","author":"Ruden","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0375","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semcdb.2003.09.024","article-title":"Waddington's widget: Hsp90 and the inheritance of acquired characters","volume":"14","author":"Ruden","year":"2003","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0380","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1389202053971947","article-title":"Epigenetic regulation of trinucleotide repeat expansions and contractions and the biased embryos hypothesis for rapid morphological evolution","volume":"6","author":"Ruden","year":"2005","journal-title":"Curr Genomics"},{"key":"10.1016\/j.bcp.2011.11.011_bib0385","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yfrne.2007.12.004","article-title":"The EDGE hypothesis: epigenetically directed genetic errors in repeat-containing proteins (RCPs) involved in evolution, neuroendocrine signaling, and cancer","volume":"29","author":"Ruden","year":"2008","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0940","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ng.743","article-title":"Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation","volume":"43","author":"Gangaraju","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2011.11.011_bib0395","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2174\/138955706778560166","article-title":"Effectiveness of hsp90 inhibitors as anti-cancer drugs","volume":"6","author":"Xiao","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/092986707779313372","article-title":"Possible effects of early treatments of hsp90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs","volume":"14","author":"Xiao","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2005.12.010","article-title":"Taxanes in paediatric oncology: and now?","volume":"32","author":"Andre","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bcp.2011.11.011_bib0410","first-page":"2139","article-title":"Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol","volume":"63","author":"Solit","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0003-4975(01)02787-4","article-title":"Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis","volume":"72","author":"Nguyen","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bcp.2011.11.011_bib0420","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-5223(99)70061-9","article-title":"Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin","volume":"118","author":"Nguyen","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bcp.2011.11.011_bib0425","first-page":"2228","article-title":"Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner","volume":"7","author":"Munster","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0430","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.leu.2402257","article-title":"The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy","volume":"15","author":"Blagosklonny","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2011.11.011_bib0435","first-page":"3940","article-title":"Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest","volume":"60","author":"Srethapakdi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.18440510102","article-title":"Ueber die Einwirkung des Ammoniaks auf Platinchlor\u00fcr","volume":"51","author":"Peyrone","year":"1844","journal-title":"Justus Liebigs Ann Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0445","first-page":"4484","article-title":"Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks","volume":"48","author":"Sorenson","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tox.2005.04.015","article-title":"Cisplatin-mediated DNA double-strand breaks in replicating but not in quiescent cells of the yeast Saccharomyces cerevisiae","volume":"212","author":"Frankenberg-Schwager","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2011.11.011_bib0455","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.65.1.235","article-title":"Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines","volume":"65","author":"Vasilevskaya","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0460","first-page":"3241","article-title":"Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of Cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction","volume":"63","author":"Vasilevskaya","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0465","first-page":"569","article-title":"Synergistic effects of geldanamycin and antitumor drugs","volume":"36","author":"Liao","year":"2001","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.bcp.2011.11.011_bib0470","first-page":"1697","article-title":"Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin","volume":"27","author":"Fedier","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0475","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijc.20611","article-title":"Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin","volume":"113","author":"Bagatell","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.11.011_bib0480","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0028-3908(01)00018-1","article-title":"Radicicol and geldanamycin prevent neurotoxic effects of anti-cancer drugs on cultured embryonic sensory neurons","volume":"40","author":"Sano","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2011.11.011_bib0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/sonc.2003.50065","article-title":"Novel biologically based therapies for Waldenstrom's macroglobulinemia","volume":"30","author":"Mitsiades","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0490","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1535-7163.551.3.5","article-title":"Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity","volume":"3","author":"Mimnaugh","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cytogfr.2004.12.001","article-title":"Tumor therapeutics by design: targeting and activation of death receptors","volume":"16","author":"Wajant","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2011.11.011_bib0500","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2008.10.005","article-title":"17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis","volume":"33","author":"Siegelin","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bcp.2011.11.011_bib0505","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-05-2698","article-title":"17-Allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0510","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bcp.2005.05.018","article-title":"17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines","volume":"70","author":"Vasilevskaya","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0515","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1535-7163.MCT-05-0129","article-title":"Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin","volume":"5","author":"Ma","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0520","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1078-0432.CCR-05-1194","article-title":"Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death","volume":"12","author":"Georgakis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0525","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/94.7.504","article-title":"Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228","volume":"94","author":"Yu","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2011.11.011_bib0530","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-04-0287","article-title":"Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824","volume":"4","author":"Chen","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0535","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0749.2005.00228.x","article-title":"Histone deacetylase inhibitors and malignant melanoma","volume":"18","author":"Boyle","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0540","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1517\/13543784.9.12.2923","article-title":"Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors","volume":"9","author":"Gore","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2011.11.011_bib0545","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1038\/sj.onc.1203176","article-title":"Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2\/Bcl-XL, c-Jun, and p21CIP1, but independent of p53","volume":"18","author":"Vrana","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.11.011_bib0550","first-page":"8420","article-title":"Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells","volume":"63","author":"Rahmani","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0555","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2004-09-3413","article-title":"Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3","volume":"105","author":"George","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.11.011_bib0560","first-page":"4483","article-title":"FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases","volume":"9","author":"Yao","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0565","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-04-0006","article-title":"Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3","volume":"64","author":"George","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0570","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2403764","article-title":"Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL\u2014inhibition of P-glycoprotein function by 17-AAG","volume":"19","author":"Radujkovic","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2011.11.011_bib0575","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.imlet.2005.11.018","article-title":"Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1","volume":"104","author":"Zsebik","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.bcp.2011.11.011_bib0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mc.20152","article-title":"Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells","volume":"45","author":"Premkumar","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.bcp.2011.11.011_bib0585","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2002-12-3785","article-title":"Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF\/MEK- and AKT-related pathways","volume":"102","author":"Jia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.11.011_bib0590","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.leu.2404140","article-title":"Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C","volume":"20","author":"Pelicano","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2011.11.011_bib0595","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood-2004-09-3523","article-title":"Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine","volume":"106","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2011.11.011_bib0600","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/nar\/gkj516","article-title":"Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage","volume":"34","author":"Barker","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0605","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-05-3692","article-title":"Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors","volume":"66","author":"Zaarur","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09553000400029460","article-title":"Heat shock protein 90 (Hsp90) chaperone complex inhibitor, radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor","volume":"81","author":"Harashima","year":"2005","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0615","first-page":"8393","article-title":"Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids","volume":"63","author":"Enmon","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0620","first-page":"8984","article-title":"Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity","volume":"63","author":"Bisht","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0625","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1749-6632.1958.tb54863.x","article-title":"Utility of drug-resistant organisms in cancer chemotherapy studies","volume":"76","author":"Schabel","year":"1958","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2011.11.011_bib0630","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molbiopara.2008.12.011","article-title":"The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities","volume":"164","author":"Wider","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0635","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/MCB.21.22.7569-7575.2001","article-title":"Hsp104 interacts with Hsp90 cochaperones in respiring yeast","volume":"21","author":"Abbas-Terki","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0640","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1091\/mbc.9.11.3071","article-title":"Hsp90 is required for pheromone signaling in yeast","volume":"9","author":"Louvion","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2011.11.011_bib0645","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2180-11-162","article-title":"Calcium\/calmodulin kinase1 and its relation to thermotolerance and HSP90 in Sporothrix schenckii: an RNAi and yeast two-hybrid study","volume":"11","author":"Rodriguez-Caban","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0650","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bcp.2011.11.011_bib0655","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2353\/ajpath.2010.091050","article-title":"Rapamycin extends maximal lifespan in cancer-prone mice","volume":"176","author":"Anisimov","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12575-009-9015-y","article-title":"The possible cellular mechanism for extending lifespan of mice with rapamycin","volume":"11","author":"Li","year":"2009","journal-title":"Biol Proced Online"},{"key":"10.1016\/j.bcp.2011.11.011_bib0665","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.011_bib0670","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1447-0594.2009.00569.x","article-title":"Effect of rapamycin on lifespan in Drosophila","volume":"10","author":"Harrison","year":"2010","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.bcp.2011.11.011_bib0675","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/1940-6207.CAPR-11-0266","article-title":"Rapamycin and mTORC1 inhibition in the mouse: skin cancer prevention","volume":"4","author":"Athar","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bcp.2011.11.011_bib0680","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/cc.10.7.15230","article-title":"The physiology and pathophysiology of rapamycin resistance: implications for cancer","volume":"10","author":"Gruppuso","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2011.11.011_bib0685","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-010-0967-z","article-title":"The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study","volume":"128","author":"Macaskill","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2011.11.011_bib0690","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-010-1055-0","article-title":"Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73","volume":"128","author":"Wong","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2011.11.011_bib0695","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature07643","article-title":"Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA","volume":"458","author":"Leidel","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.011_bib0700","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/jbiol56","article-title":"Multilevel regulation of growth rate in yeast revealed using systems biology","volume":"6","author":"Ramanathan","year":"2007","journal-title":"J Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0705","first-page":"2132","article-title":"Clinical results with hydroxyurea in cancer chemotherapy; preliminary report","volume":"65","author":"Cole","year":"1965","journal-title":"N Y State J Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0710","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt196455574","article-title":"Clinical trials of hydroxyurea in patients with cancer and leukemia","volume":"5","author":"Fishbein","year":"1964","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.11.011_bib0715","first-page":"43","article-title":"Phase II studies of hydroxyurea (Nsc-32065) in adults: cancer of the breast","volume":"40","author":"Sears","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bcp.2011.11.011_bib0720","first-page":"41","article-title":"Trial of hydroxyurea (Nsc-32065) in cancer in children","volume":"37","author":"Origenes","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bcp.2011.11.011_bib0725","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cncr.25374","article-title":"Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer","volume":"117","author":"Kao","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2011.11.011_bib0730","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1432-1033.1991.tb15810.x","article-title":"Deoxyribonucleotide metabolism in hydroxyurea-resistant V79 hamster cells","volume":"196","author":"Hoglund","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0735","first-page":"526","article-title":"Hydroxyurea-induced inhibition of deoxyribonucleotide synthesis: studies in intact cells","volume":"27","author":"Young","year":"1967","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0740","first-page":"610","article-title":"Gene RAD31 is identical to gene MEC1 of yeast Saccharomyces cerevisiae","volume":"47","author":"Kozhina","year":"2011","journal-title":"Genetika"},{"key":"10.1016\/j.bcp.2011.11.011_bib0745","doi-asserted-by":"crossref","first-page":"e1000763","DOI":"10.1371\/journal.pgen.1000763","article-title":"Elevated levels of the polo kinase Cdc5 override the Mec1\/ATR checkpoint in budding yeast by acting at different steps of the signaling pathway","volume":"6","author":"Donnianni","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.bcp.2011.11.011_bib0750","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10577-007-1145-y","article-title":"Meiotic roles of Mec1, a budding yeast homolog of mammalian ATR\/ATM","volume":"15","author":"Carballo","year":"2007","journal-title":"Chromosome Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0755","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(95)90480-8","article-title":"TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1","volume":"82","author":"Morrow","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.11.011_bib0760","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1096\/fj.08-121046","article-title":"Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis","volume":"23","author":"Lee","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2011.11.011_bib0765","first-page":"61","article-title":"Role of immune skin reactions in progressive lung cancer during the administration of OK-432\u2014relation to reactions to DNCB, PPD and Su-PS","volume":"14","author":"Katada","year":"1987","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.bcp.2011.11.011_bib0770","first-page":"45","article-title":"DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up","volume":"32","author":"Munzarova","year":"1985","journal-title":"Neoplasma"},{"key":"10.1016\/j.bcp.2011.11.011_bib0775","first-page":"385","article-title":"DNCB and PPD skin testing in breast cancer","volume":"30","author":"Munzarova","year":"1983","journal-title":"Neoplasma"},{"key":"10.1016\/j.bcp.2011.11.011_bib0780","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/1097-0142(197604)37:4<1696::AID-CNCR2820370413>3.0.CO;2-9","article-title":"A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer","volume":"37","author":"Cunningham","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2011.11.011_bib0785","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJM197207062870117","article-title":"DNCB test in cancer patients","volume":"287","author":"Sadoff","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0790","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1074\/jbc.M610646200","article-title":"Roles of bound quinone in the single subunit NADH-quinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae","volume":"282","author":"Yamashita","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0795","doi-asserted-by":"crossref","first-page":"37774","DOI":"10.1074\/jbc.M007033200","article-title":"Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells","volume":"275","author":"Seo","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0800","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0005-2728(99)00051-1","article-title":"Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae","volume":"1412","author":"Seo","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.11.011_bib0805","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1021\/ac901174g","article-title":"Differential rates of glutathione oxidation for assessment of cellular redox status and antioxidant capacity by capillary electrophoresis-mass spectrometry: an elusive biomarker of oxidative stress","volume":"81","author":"Lee","year":"2009","journal-title":"Anal Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0810","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/HYPERTENSIONAHA.109.133983","article-title":"Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin","volume":"54","author":"Xu","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2011.11.011_bib0815","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1179\/135100006X100986","article-title":"Direct measurement of the rate of glutathione synthesis in 1-chloro-2,4-dinitrobenzene treated human erythrocytes","volume":"11","author":"Raftos","year":"2006","journal-title":"Redox Rep"},{"key":"10.1016\/j.bcp.2011.11.011_bib0820","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.freeradbiomed.2005.01.002","article-title":"Redox regulation of the signaling pathways leading to eNOS phosphorylation","volume":"38","author":"Tanaka","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bcp.2011.11.011_bib0825","doi-asserted-by":"crossref","first-page":"C2003","DOI":"10.1152\/ajpcell.2001.281.6.C2003","article-title":"GSH depletion, K\u2013Cl cotransport, and regulatory volume decrease in high-K\/high-GSH dog red blood cells","volume":"281","author":"Fujise","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0830","first-page":"H278","article-title":"Reductant substrate for glutathione peroxidase modulates oxidant inhibition of Ca2+ signaling in endothelial cells","volume":"268","author":"Elliott","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0835","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/jrf.0.0880259","article-title":"Effect of glutathione depletion on the cytotoxicity of xenobiotics and induction of single-strand DNA breaks by ionizing radiation in isolated hamster round spermatids","volume":"88","author":"Den Boer","year":"1990","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.bcp.2011.11.011_bib0840","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/0006-2952(89)90530-3","article-title":"Glutathione redox state, lipid peroxide levels, and activities of glutathione enzymes in oltipraz-treated adult Schistosoma mansoni","volume":"38","author":"Mkoji","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0845","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI111263","article-title":"Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide","volume":"73","author":"Harlan","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2011.11.011_bib0850","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1073\/pnas.0911539107","article-title":"Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction","volume":"107","author":"Sanz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.11.011_bib0855","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tcb.2011.06.008","article-title":"Taking a good look at free radicals in the aging process","volume":"21","author":"Hekimi","year":"2011","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0860","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/genetics\/120.3.725","article-title":"The effect of sequence homozygosity on the frequency of X-chromosomal exchange in Drosophila melanogaster females","volume":"120","author":"Rutherford","year":"1988","journal-title":"Genetics"},{"key":"10.1016\/j.bcp.2011.11.011_bib0865","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ng0103-6","article-title":"Quantitative epigenetics","volume":"33","author":"Rutherford","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2011.11.011_bib0870","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10637-009-9381-y","article-title":"Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and\/or cisplatin in patients with refractory solid tumors","volume":"29","author":"Hubbard","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2011.11.011_bib0875","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3171\/2009.3.JNS081146","article-title":"Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells","volume":"112","author":"Ohba","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bcp.2011.11.011_bib0880","doi-asserted-by":"crossref","first-page":"e21632","DOI":"10.1371\/journal.pone.0021632","article-title":"Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance","volume":"6","author":"Oikonomou","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2011.11.011_bib0885","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1871520611009060504","article-title":"Combination therapy with arsenic trioxide for hematological malignancies","volume":"10","author":"Takahashi","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0890","first-page":"5126","article-title":"Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells","volume":"63","author":"Nimmanapalli","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0895","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1677\/ERC-09-0318","article-title":"Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors","volume":"17","author":"Gilbert","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bcp.2011.11.011_bib0900","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.leu.2403881","article-title":"Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway","volume":"19","author":"Yao","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2011.11.011_bib0905","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/JTO.0b013e31822adfb0","article-title":"Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach","volume":"6","author":"Reka","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0910","doi-asserted-by":"crossref","first-page":"52572","DOI":"10.1074\/jbc.M309054200","article-title":"Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress","volume":"278","author":"Arlander","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.011_bib0915","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/1078-0432.CCR-06-1750","article-title":"Synergism between etoposide and 17-AAG in leukemia cells: critical roles for Hsp90, FLT3, topoisomerase II, Chk1, and Rad51","volume":"13","author":"Yao","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.011_bib0920","doi-asserted-by":"crossref","first-page":"794901","DOI":"10.1155\/2009\/794901","article-title":"Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma","volume":"2009","author":"Nguyen","year":"2009","journal-title":"Sarcoma"},{"key":"10.1016\/j.bcp.2011.11.011_bib0925","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2008.07053.x","article-title":"Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling","volume":"141","author":"Al Shaer","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2011.11.011_bib0930","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/nnm.10.133","article-title":"Synergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices","volume":"6","author":"Huang","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bcp.2011.11.011_bib0935","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/187152008784533062","article-title":"HER-2 positive breast cancer: what else beyond trastuzumab-based therapy","volume":"8","author":"Widakowich","year":"2008","journal-title":"Anticancer Agents Med Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211008483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211008483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T04:00:30Z","timestamp":1686456030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211008483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":187,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0006295211008483"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.11.011","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}